바이오모아 (BioMoa) — ADC · Antibody

8428프로그램 40FDA 승인

85오늘 방문

1,565누적 방문

7303갱신 대기 S–CData Tier S/A/B차세대 →Insight 1032HER2 breast 4683Antibody 2713CGT →Psoriasis →NSCLC 40FDA 승인

피드 Data Tier 차세대 Insight

최근 활동

RSS →

AntibodystaleRochePhase 2

Trifluridine-tipiracil plus Bevacizumab Alone (Trifluridine-tipiracil plus Bevacizumab Alone)

Refractory Metastatic Colorectal Cancer · FRα

#FR#Antibody#Phase2#항체#면역항체+3

임상시험 1상태 RECRUITING

AntibodystaleRochePreclinical

Capecitabine (Xeloda, Capecitabine, Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Preclinical#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleBeiGenePhase 2

Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed (Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed)

Non-squamous Non-small Cell Lung Cancer; EGFR Gene Mutation · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4

임상시험 1상태 ACTIVE

CGTBiologicstaleTCRCure Biopharma Ltd.Phase 1

HPV E6-specific TCR-T cells (HPV E6-specific TCR-T cells)

Cervical Cancer; Head and Neck Squamous Cell Carcinoma · Cervical Cancer

#CervicalCancer#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 ACTIVE

AntibodystaleJanssenApproved

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Approved#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleJanssenApproved

Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab (Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleJanssenApproved

Innovator infliximab (Innovator infliximab)

Rheumatoid Arthritis; Spondyloarthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+3

임상시험 1상태 ACTIVE

AntibodystaleAbbViePhase 3

adalimumab (Humira, Human anti-TNF monoclonal antibody/adalimumab)

Psoriatic Arthritis · Psoriatic Arthritis

#PsoriaticArthritis#Antibody#Phase3#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleAbbViePhase 3

proposed biosimilar to adalimumab (SB5, SB5 (proposed biosimilar to adalimumab))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleAbbViePreclinical

Alvotech Biosimilar to Adalimumab (AVT02, AVT02 (Alvotech Biosimilar to Adalimumab))

Crohn Disease; Ulcerative Colitis · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+3

임상시험 1상태 ACTIVE

CGTBiologicstaleSabz BiomedicalsPhase 1

CD19 CAR engineered autologous T-cells (CD19 CAR engineered autologous T-cells)

Relapsed B Cell Acute Lymphoblastic Leukemia (ALL); Refractory B Cell Acute Lymphoblastic Leukemia (ALL) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 ACTIVE

AntibodystaleMoonLake Immunotherapeutics AGPhase 2

M1095 (Sonelokimab, Sonelokimab (M1095))

Hidradenitis Suppurativa · Hidradenitis Suppurativa

#HidradenitisSuppurativa#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleAbbViePhase 3

adalimumab (Humira, Double-blind adalimumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleSanofiPreclinical

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis With Nasal Polyps

#ChronicRhinosinusitisWithNasalPo#Antibody#Preclinical#항체#면역항체+2

임상시험 1상태 RECRUITING

AntibodystaleNovartis PharmaceuticalsPhase 3

AIN457 (Canakinumab, Canakinumab (AIN457))

Periodic Fevers Syndrome · Periodic Fevers Syndrome

#PeriodicFeversSyndrome#Antibody#Phase3#항체#면역항체+2

임상시험 1상태 ACTIVE

CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

(PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte (PG13-A(F/K-F-SGSG-T2a-B (opt, (PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte)

Renal Cancer; Kidney Cancer · Renal Cancer

#RenalCancer#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 DISCONTINUED

AntibodystaleRochePhase 1

trastuzumab (Herceptin, ABI-007/carboplatin/trastuzumab)

Advanced Adult Primary Liver Cancer; Anaplastic Thyroid Cancer · Advanced Adult Primary Liver Cancer

#AdvancedAdultPrimaryLiverCancer#Antibody#Phase1#항체#면역항체+3

효능 ORR 12%임상시험 1상태 ACTIVE

CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

T cell injection targeting FLT3 chimeric antigen receptor (T cell injection targeting FLT3 chimeric antigen receptor)

FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 ACTIVE

CGTBiologicstaleSeattle Children's HospitalPhase 1

EGFR806-specific chimeric antigen receptor (CAR, EGFR806-specific chimeric antigen receptor, EGFR806-specific chimeric antigen receptor (CAR) T cell)

Central Nervous System Tumor, Pediatric; Glioma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+5

임상시험 1상태 ACTIVE

CGTBiologicstaleMingfeng ZhaoPhase 1

universal CLL1 CAR-T cells (universal CLL1 CAR-T cells)

Acute Myeloid Leukemia; Chimeric Antigen Receptor T-cell · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

CGTBiologicstaleTechnische Universität DresdenPhase 1

BCMA directed CAR T-cells (MDC-CAR-BCMA001, MDC-CAR-BCMA001 (BCMA directed CAR T-cells))

Neoplasms; Relapsed Diffuse Large B-cell Lymphoma (DLBCL) · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING

CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

T cell injection targeting B7-H3 chimeric antigen receptor (T cell injection targeting B7-H3 chimeric antigen receptor)

B7-H3-positive Relapsed/ Refractory Neuroblastoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING

CGTBiologicstaleUniversity of Colorado, DenverPhase 1

CD19x22 CAR T (CD19x22 CAR T)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

CGTBiologicstaleSeattle Children's HospitalPhase 1

HER2-specific chimeric antigen receptor (CAR, HER2-specific chimeric antigen receptor, HER2-specific chimeric antigen receptor (CAR) T cell)

Central Nervous System Tumor, Pediatric; Glioma · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+5

임상시험 1상태 RECRUITING

ADCCFDAFDABiologicFDA approved (openFDA)Approved

TELISOTUZUMAB VEDOTIN-TLLV (TELISOTUZUMAB VEDOTIN-TLLV)

FDA-approved indication · See label

#Seelabel#ADC#Approved#FDA승인#항체약물접합체+3

임상시험 0상태 APPROVED

141 / 142 페이지

← 이전 다음 →

전체 8,428개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 85 / 1,565

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

Trifluridine-tipiracil plus Bevacizumab Alone (Trifluridine-tipiracil plus Bevacizumab Alone)

Capecitabine (Xeloda, Capecitabine, Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab)

Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed (Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed)

HPV E6-specific TCR-T cells (HPV E6-specific TCR-T cells)

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab (Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab)

Innovator infliximab (Innovator infliximab)

adalimumab (Humira, Human anti-TNF monoclonal antibody/adalimumab)

proposed biosimilar to adalimumab (SB5, SB5 (proposed biosimilar to adalimumab))

Alvotech Biosimilar to Adalimumab (AVT02, AVT02 (Alvotech Biosimilar to Adalimumab))

CD19 CAR engineered autologous T-cells (CD19 CAR engineered autologous T-cells)

M1095 (Sonelokimab, Sonelokimab (M1095))

adalimumab (Humira, Double-blind adalimumab)

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

AIN457 (Canakinumab, Canakinumab (AIN457))

(PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte (PG13-A(F/K-F-SGSG-T2a-B (opt, (PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte)

trastuzumab (Herceptin, ABI-007/carboplatin/trastuzumab)

T cell injection targeting FLT3 chimeric antigen receptor (T cell injection targeting FLT3 chimeric antigen receptor)

EGFR806-specific chimeric antigen receptor (CAR, EGFR806-specific chimeric antigen receptor, EGFR806-specific chimeric antigen receptor (CAR) T cell)

universal CLL1 CAR-T cells (universal CLL1 CAR-T cells)

BCMA directed CAR T-cells (MDC-CAR-BCMA001, MDC-CAR-BCMA001 (BCMA directed CAR T-cells))

T cell injection targeting B7-H3 chimeric antigen receptor (T cell injection targeting B7-H3 chimeric antigen receptor)

CD19x22 CAR T (CD19x22 CAR T)

HER2-specific chimeric antigen receptor (CAR, HER2-specific chimeric antigen receptor, HER2-specific chimeric antigen receptor (CAR) T cell)

TELISOTUZUMAB VEDOTIN-TLLV (TELISOTUZUMAB VEDOTIN-TLLV)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

Trifluridine-tipiracil plus Bevacizumab Alone (Trifluridine-tipiracil plus Bevacizumab Alone)

Capecitabine (Xeloda, Capecitabine, Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab)

Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed (Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed)

HPV E6-specific TCR-T cells (HPV E6-specific TCR-T cells)

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab (Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab)

Innovator infliximab (Innovator infliximab)

adalimumab (Humira, Human anti-TNF monoclonal antibody/adalimumab)

proposed biosimilar to adalimumab (SB5, SB5 (proposed biosimilar to adalimumab))

Alvotech Biosimilar to Adalimumab (AVT02, AVT02 (Alvotech Biosimilar to Adalimumab))

CD19 CAR engineered autologous T-cells (CD19 CAR engineered autologous T-cells)

M1095 (Sonelokimab, Sonelokimab (M1095))

adalimumab (Humira, Double-blind adalimumab)

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

AIN457 (Canakinumab, Canakinumab (AIN457))

(PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte (PG13-A(F/K-F-SGSG-T2a-B (opt, (PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte)

trastuzumab (Herceptin, ABI-007/carboplatin/trastuzumab)

T cell injection targeting FLT3 chimeric antigen receptor (T cell injection targeting FLT3 chimeric antigen receptor)

EGFR806-specific chimeric antigen receptor (CAR, EGFR806-specific chimeric antigen receptor, EGFR806-specific chimeric antigen receptor (CAR) T cell)

universal CLL1 CAR-T cells (universal CLL1 CAR-T cells)

BCMA directed CAR T-cells (MDC-CAR-BCMA001, MDC-CAR-BCMA001 (BCMA directed CAR T-cells))

T cell injection targeting B7-H3 chimeric antigen receptor (T cell injection targeting B7-H3 chimeric antigen receptor)

CD19x22 CAR T (CD19x22 CAR T)

HER2-specific chimeric antigen receptor (CAR, HER2-specific chimeric antigen receptor, HER2-specific chimeric antigen receptor (CAR) T cell)

TELISOTUZUMAB VEDOTIN-TLLV (TELISOTUZUMAB VEDOTIN-TLLV)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

Trifluridine-tipiracil plus Bevacizumab Alone (Trifluridine-tipiracil plus Bevacizumab Alone)

Capecitabine (Xeloda, Capecitabine, Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab)

Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed (Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed)

HPV E6-specific TCR-T cells (HPV E6-specific TCR-T cells)

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab (Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab)

Innovator infliximab (Innovator infliximab)

adalimumab (Humira, Human anti-TNF monoclonal antibody/adalimumab)

proposed biosimilar to adalimumab (SB5, SB5 (proposed biosimilar to adalimumab))

Alvotech Biosimilar to Adalimumab (AVT02, AVT02 (Alvotech Biosimilar to Adalimumab))

CD19 CAR engineered autologous T-cells (CD19 CAR engineered autologous T-cells)

M1095 (Sonelokimab, Sonelokimab (M1095))

adalimumab (Humira, Double-blind adalimumab)

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

AIN457 (Canakinumab, Canakinumab (AIN457))

(PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte (PG13-A(F/K-F-SGSG-T2a-B (opt, (PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte)